Aptinyx (APTX) Stock Forecast, Price Target & Predictions
APTX Stock Forecast
Aptinyx stock forecast is as follows: an average price target of $1.00 (represents a 941.67% upside from APTX’s last price of $0.10) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
APTX Price Target
APTX Analyst Ratings
Aptinyx Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 26, 2022 | - | H.C. Wainwright | $1.00 | $0.40 | 153.10% | 941.67% |
Aptinyx Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $0.10 | $0.10 | $0.10 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 15, 2022 | BMO Capital | Outperform | Outperform | Hold |
Aug 05, 2022 | SVB Leerink | Outperform | Outperform | Hold |
May 18, 2022 | Piper Sandler | Overweight | Overweight | Hold |
Aptinyx Financial Forecast
Aptinyx Revenue Forecast
Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Mar 21 | Oct 20 | Jul 20 | Mar 20 | Oct 19 | Jul 19 | Mar 19 | Oct 18 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | $1.00M | - | - | $818.00K | - | - | $890.00K | - | - |
Avg Forecast | - | - | - | - | - | - | $1.40M | $1.00M | $301.31K | $508.15K | $769.88K | $936.00K | $1.34M | $801.00K | $2.21M | $3.47M |
High Forecast | - | - | - | - | - | - | $1.40M | $1.00M | $301.31K | $508.15K | $769.88K | $936.00K | $1.34M | $801.00K | $2.21M | $3.47M |
Low Forecast | - | - | - | - | - | - | $1.40M | $1.00M | $301.31K | $508.15K | $769.88K | $936.00K | $1.34M | $801.00K | $2.21M | $3.47M |
# Analysts | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - | 1.00% | - | - | 1.06% | - | - | 1.11% | - | - |
Aptinyx EBITDA Forecast
Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Mar 21 | Oct 20 | Jul 20 | Mar 20 | Oct 19 | Jul 19 | Mar 19 | Oct 18 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | $-20.00M | $-13.81M | - | - | $-14.60M | - | - | $-16.59M | - | - |
Avg Forecast | - | - | - | - | - | - | $-840.00K | $-13.81M | $-13.17M | $-12.86M | $-13.69M | $-14.68M | $-15.71M | $-14.75M | $-19.92M | $3.30M |
High Forecast | - | - | - | - | - | - | $-840.00K | $-11.05M | $-10.54M | $-10.29M | $-10.95M | $-11.74M | $-12.57M | $-11.80M | $-15.94M | $3.96M |
Low Forecast | - | - | - | - | - | - | $-840.00K | $-16.58M | $-15.80M | $-15.43M | $-16.43M | $-17.61M | $-18.85M | $-17.70M | $-23.91M | $2.64M |
Surprise % | - | - | - | - | - | - | 23.81% | 1.00% | - | - | 1.07% | - | - | 1.13% | - | - |
Aptinyx Net Income Forecast
Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Mar 21 | Oct 20 | Jul 20 | Mar 20 | Oct 19 | Jul 19 | Mar 19 | Oct 18 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | - | - | - | - | - | - | $-21.81M | $-14.23M | - | - | $-14.71M | - | - | $-16.71M | - | - |
Avg Forecast | $104.38M | $90.91M | $106.75M | $-5.42M | $-3.39M | $-15.57M | $-12.87M | $-14.23M | $-13.29M | $-12.96M | $-13.79M | $-14.79M | $-15.86M | $-14.85M | $-20.09M | $0.48 |
High Forecast | $104.38M | $90.91M | $106.75M | $-5.42M | $-3.39M | $-15.57M | $-12.87M | $-11.38M | $-10.63M | $-10.37M | $-11.03M | $-11.83M | $-12.69M | $-11.88M | $-16.07M | $0.48 |
Low Forecast | $104.38M | $90.91M | $106.75M | $-5.42M | $-3.39M | $-15.57M | $-12.87M | $-17.07M | $-15.95M | $-15.56M | $-16.55M | $-17.75M | $-19.04M | $-17.83M | $-24.11M | $0.48 |
Surprise % | - | - | - | - | - | - | 1.70% | 1.00% | - | - | 1.07% | - | - | 1.13% | - | - |
Aptinyx SG&A Forecast
Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Mar 21 | Oct 20 | Jul 20 | Mar 20 | Oct 19 | Jul 19 | Mar 19 | Oct 18 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
SG&A | - | - | - | - | - | - | $4.23M | $4.98M | - | - | $4.90M | - | - | $5.72M | - | - |
Avg Forecast | - | - | - | - | - | - | - | $4.98M | $5.92M | $4.94M | $4.59M | $4.52M | $5.45M | $5.09M | $5.36M | $3.30M |
High Forecast | - | - | - | - | - | - | - | $5.97M | $7.10M | $5.93M | $5.51M | $5.43M | $6.55M | $6.11M | $6.43M | $3.96M |
Low Forecast | - | - | - | - | - | - | - | $3.98M | $4.74M | $3.95M | $3.67M | $3.62M | $4.36M | $4.07M | $4.29M | $2.64M |
Surprise % | - | - | - | - | - | - | - | 1.00% | - | - | 1.07% | - | - | 1.13% | - | - |
Aptinyx EPS Forecast
Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Mar 21 | Oct 20 | Jul 20 | Mar 20 | Oct 19 | Jul 19 | Mar 19 | Oct 18 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS | - | - | - | - | - | - | $-0.32 | $-0.22 | - | - | $-0.34 | - | - | $-0.50 | - | - |
Avg Forecast | $1.54 | $1.34 | $1.58 | $-0.08 | $-0.05 | $-0.23 | $-0.19 | $-0.21 | $-0.30 | $-0.29 | $-0.33 | $-0.46 | $-0.52 | $-0.46 | $-0.48 | $-22.15M |
High Forecast | $1.54 | $1.34 | $1.58 | $-0.08 | $-0.05 | $-0.23 | $-0.19 | $-0.21 | $-0.30 | $-0.29 | $-0.33 | $-0.46 | $-0.52 | $-0.46 | $-0.48 | $-26.58M |
Low Forecast | $1.54 | $1.34 | $1.58 | $-0.08 | $-0.05 | $-0.23 | $-0.19 | $-0.21 | $-0.30 | $-0.29 | $-0.33 | $-0.46 | $-0.52 | $-0.46 | $-0.48 | $-17.72M |
Surprise % | - | - | - | - | - | - | 1.68% | 1.05% | - | - | 1.03% | - | - | 1.09% | - | - |
Aptinyx Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ADTX | Aditxt | $0.49 | $160.00 | 32553.06% | - |
APTX | Aptinyx | $0.06 | $1.00 | 1566.67% | Buy |
RVPH | Reviva Pharmaceuticals | $1.00 | $10.00 | 900.00% | Buy |
SPRO | Spero Therapeutics | $1.29 | $10.00 | 675.19% | Buy |
CTMX | CytomX Therapeutics | $1.01 | $5.77 | 471.29% | Buy |
ATXI | Avenue Therapeutics | $2.20 | $12.00 | 445.45% | Buy |
NUVB | Nuvation Bio | $2.29 | $6.75 | 194.76% | Buy |
TIL | Instil Bio | $27.63 | $78.25 | 183.21% | Hold |
ASMB | Assembly Biosciences | $16.98 | $35.50 | 109.07% | Buy |
ACHL | Achilles Therapeutics | $1.03 | $2.00 | 94.17% | Buy |
APTX Forecast FAQ
Is Aptinyx a good buy?
Yes, according to 3 Wall Street analysts, Aptinyx (APTX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of APTX's total ratings.
What is APTX's price target?
Aptinyx (APTX) average price target is $1 with a range of $1 to $1, implying a 941.67% from its last price of $0.096. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Aptinyx stock go up soon?
According to Wall Street analysts' prediction for APTX stock, the company can go up by 941.67% (from the last price of $0.096 to the average price target of $1), up by 941.67% based on the highest stock price target, and up by 941.67% based on the lowest stock price target.
Can Aptinyx stock reach $0?
APTX's average twelve months analyst stock price target of $1 supports the claim that Aptinyx can reach $0 in the near future.
What are Aptinyx's analysts' financial forecasts?
APTX's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $1.4M (high $1.4M, low $1.4M), average EBITDA is $-840K (high $-840K, low $-840K), average net income is $-37.244M (high $-37.244M, low $-37.244M), average SG&A $0 (high $0, low $0), and average EPS is $-0.55 (high $-0.55, low $-0.55).
Did the APTX's actual financial results beat the analysts' financial forecasts?
In terms of the last quarterly report (Mar 2021), Aptinyx's revenue was $1M, beating the average analysts' forecast of $1M by 0%. The company's EBITDA was $-13.814M, beating the average prediction of $-13.814M by 0%. Aptinyx's net income was $-14.226M, beating the average estimation of $-14.226M by 0%. The company's SG&A was $4.98M, beating the average forecast of $4.98M by 0%. Lastly, the company's EPS was $-0.22, beating the average prediction of $-0.21 by 4.76%